血管内皮生长因子、肿瘤血管生成与头颈部肿瘤
Vascular Endothelial Growth Factor,Tumor Vessel Genesis and Cancers of Head and Neck
出处
《同济大学学报（医学版）》
CAS
2003年第3期252-255,共4页
Journal of Tongji University(Medical Science)
参考文献20
-
1Denhart BC, Guidi AJ,Tognazzi K, et al. Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia[J]. Lab Invest, 1997, 77(6) : 659 -664.
-
2Guang W H, Stmagawa M. The relationship between microvessel density, the expression of vascular endothelial growth factor(VEGF), and the extension of nasopharyngeal carcinoma[J]. Laryngoscope, 2000, 110 (12) :2066 - 2069.
-
3Riedal F, GotteK, Sehwalb J, et al. Vascular endothelial growth factor expression correlates with P53 mutation and angiogenesis in squamous cell carcinoma of the head and neck[J]. Acta Otolarygol, 2000,120(1) : 105 - 111.
-
4Tae K, Naggar AK, Yoo E, et al. Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis [ J ]. Clin Cancer Res, 2000, 6(7) :2821 - 2828.
-
5Carlile J, Harada K, Baillie R, et al. Vscular endothelial growth factor(VEGF) expression in oral tissues: possible relevance to angiogenesis,tumor progression and field cancerisation[J]. J Oral Pathol Med, 2001,30(8) : 449-457.
-
6Riedel F, Gotte K, Schwalb J, et al. Serum levels of vascular endothelial grow factor in patients with head and neck cancer[J]. Eur Arch Otorhinolaryngol, 2000,257(6) :332 - 336.
-
7Humer J J, Anyanwu K, Ell SR, et al. Serum vascular endothelial growth factor in patients with head and neck squamous cell carcinoma[J]. Clin Otolaryngol, 1999,24(5) :426 - 430.
-
8Becker A, Stadler P, Krause U, et al. Association between elevated serum VEGF and polarographically measured tumor hypoxia in head and neck carcinomas[J].Strahlenther Onkol,2001,177(4) : 182 - 188.
-
9Vitolo D, Ciocci L, Cicerone E, et al. Laminin aipha 2 chain(merosin M)distribution and VEGF, FGF-2, and TGT betal gene expression in angiogenesis of supraglottic,lung and breast carcinomas[J]. J Pathol,2001,195(2) : 197 - 208.
-
10Lukits J,Timar J,Juhasz A, et al. Progression difference between cancers of the larynx and hypopharynx is not due to tumor size and vascularization [ J ]. Otolaryngol,2001,125 (1) : 18 - 22.
-
1张辉,孔北华.肿瘤标志物在妇科肿瘤中的应用进展[J].中国实用妇科与产科杂志,2006,22(1):9-13. 被引量：19
-
2王鑫,支修益.肺癌血清肿瘤标志物的临床应用研究进展[J].中华医学信息导报,2016,0(22):19-19.
-
3詹仁雅,潘剑威.一氧化氮对肿瘤血管生成的作用[J].中华神经外科疾病研究杂志,2005,4(1):86-87.
-
4白敬洋,衣服新,马俊,常锐.替莫唑胺对大鼠垂体腺瘤GH3细胞增殖及其激素分泌的影响[J].山东医药,2012,52(26):20-22. 被引量：2
-
5张冬青.肿瘤标志物检测及其应用[J].中国医刊,2010,45(4):89-91. 被引量：1
-
6丁树平,曾进,周四维.肾细胞癌血管生成与癌细胞转移的关系[J].临床泌尿外科杂志,2000,15(8):366-367. 被引量：4
-
7杨俊,刘继红,李本义.β_2微球蛋白与前列腺癌[J].现代泌尿生殖肿瘤杂志,2009,1(2):65-68.
-
8张晓霏,彭芝兰.肾上腺髓质素与肿瘤血管生成的研究进展[J].中华妇幼临床医学杂志（电子版）,2007,3(1):56-58. 被引量：1
-
9赵超,马云宝.肝硬化及原发性肝癌患者血清胰岛素样生长因子-Ⅱ、TNF和IL-6水平的研究[J].肝脏,2001,6(4):250-250. 被引量：1
-
10文荣,周成江,贾彦彬.MUC1和MUC2在胃癌患者中的表达及其研究进展[J].包头医学院学报,2016,32(2):165-166. 被引量：1
